2nd Quarter - Report

CAPITOL SOLUTIONS for AMGEN USA

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

P.L. 111-148, The Patient Protection and Affordable Care Act; Issues related to Sec.7002, biologics, and Sec. 10336, dialysis services - Medicare bundling payment system H.R. 4872, The Reconciliation Act of 2010

LobbyistCovered position, as disclosed
DON LYSTER —
DANIEL C TATE —

Contacted: HOUSE OF REPRESENTATIVES

Bills named: H.R. 4872 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.